The Business Research Company’s report on the Depyrogenated Sterile Empty Vials Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
Which emerging drivers are set to accelerate the growth of the depyrogenated sterile empty vials market further?
The increasing prevalence of infectious diseases across the globe is expected to propel the growth of the depyrogenated sterile empty vials market. Infectious diseases refer to conditions caused by harmful microorganisms such as bacteria, viruses, parasites, and fungi. Depyrogenated sterile vials are used for the storage of injectable medication involved in the treatment of infectious diseases. Additionally, depyrogenated sterile empty vials are also used for the collection of laboratory samples. For instance, in February 2024, according to the Health Security Agency, a UK-based government agency, cases of tuberculosis (TB) in England increased by 10.7% in 2023 compared to 2022. The number of cases rose from 4,380 in 2022 to 4,850 in 2023. Therefore, the increasing prevalence of infectious diseases across the globe will drive the growth of the depyrogenated sterile empty vials market.
Access Your Free Sample of the Global Depyrogenated Sterile Empty Vials Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=8562&type=smp
What are the key factors influencing the forecasted market size of the depyrogenated sterile empty vials industry?
The depyrogenated sterile empty vials market size has grown strongly in recent years. It will grow from $3.63 billion in 2024 to $3.83 billion in 2025 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historic period can be attributed to rise in pharmaceutical manufacturing, stringent regulatory standards, focus on drug stability and purity, increase in contract manufacturing, expansion of clinical trials, introduction of high-value biologics, focus on patient safety, shift towards ready-to-use components.
The depyrogenated sterile empty vials market size is expected to see strong growth in the next few years. It will grow to $5.25 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to focus on advanced drug delivery systems, increasing regulatory emphasis on container closure integrity, rise in personalized medicine approaches, expansion of biomanufacturing facilities, focus on sustainable packaging, digitalization of supply chain management, demand for high-value oncology drugs. Major trends in the forecast period include single-use technologies, biological drug development, quality by design (QBD) approaches, biodegradable and sustainable materials, digitalization in supply chain management, smart packaging technologies, advancements in aseptic filling technologies, collaborations and partnerships, .
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=8562&type=smp
Who are the leading competitors in the depyrogenated sterile empty vials market?
Major companies operating in the depyrogenated sterile empty vials market are APG Pharma, Corning Inc., DWK Life Sciences, Nipro PharmaPackaging, Schott AG, Thermo Fisher Scientific, Gerresheimer AG, Stevanato Group, SGD Pharma, Merck KGaA, SiO2 Materials Science, Shandong Pharmaceutical Glass Co. Ltd., West Pharmaceutical Services Inc., Ompi Srl, AptarGroup Inc., Pacific Vial Manufacturing Inc., Adelphi Healthcare Packaging Limited, Acme Vial and Glass Company LLC, Amposan S.A., BMT Corporation, Cangzhou Four Stars Glass Co. Ltd., Ciron Drugs & Pharmaceuticals Pvt. Ltd., Zhejiang Pharmaceutical-Packaging Co. Ltd., Verpakkingsindustrie B.V.,
Which emerging trends are set to transform the depyrogenated sterile empty vials market landscape?
Technological advancements have emerged as a key trend gaining popularity in the depyrogenated sterile empty vials market. Major companies operating in the depyrogenated sterile empty vials market are focused on incorporating advanced technologies in depyrogenated sterile empty vials for better quality and to sustain their position in the market. For instance, in November 2022, Gerresheimer AG, a Germany-based a drug packaging company, together with Stevanato Group S.p.A., an Italy-based provider of drug containment, drug delivery and diagnostic solutions, launched the EZ-fill Smart platform. The new EZ-fill Smart platform is a Ready-To-Fill solution for the global vial market, aimed at enhancing drug packaging quality, reducing total cost of ownership (TCO), and shortening lead times for customers. As an evolution of Stevanato Group’s pioneering EZ-fill platform, EZ-fill Smart introduces key advancements that can significantly improve customer product offerings, meeting the growing demand for ready-to-use vials.
How do different geographies compare in terms of market share and growth potential in the depyrogenated sterile empty vials market?
North America was the largest region in the depyrogenated sterile empty vials market in 2024. The regions covered in the depyrogenated sterile empty vials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Order Your Report Now For Swift Delivery
Which major segments of the depyrogenated sterile empty vials market are experiencing the fastest growth?
The depyrogenated sterile empty vials market covered in this report is segmented –
1) By Product: 2 ML, 5 ML, 10 ML, 20 ML, >20 ML
2) By Packaging: Glass, Plastic
3) By End User: Clinical Labs, Compounding Labs, Pharmaceutical Companies, Contract Manufacturing Organization, Distributors
Subsegments:
1) By 2 ML: Single-Use Vials, Multi-Dose Vials
2) By 5 ML: Single-Use Vials, Multi-Dose Vials
3) By 10 ML: Single-Use Vials, Multi-Dose Vials
4) By 20 ML: Single-Use Vials, Multi-Dose Vials
5) By >20 ML: Single-Use Vials, Multi-Dose Vials
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8562
How is the depyrogenated sterile empty vials market defined?
Depyrogenated sterile empty vials refer to borosilicate glass containers with butyl-rubber stoppers and aluminum seals used for injectable drug storage. Depyrogenation is referred to as the elimination of pyrogenic substances including bacterial endotoxins through the application of heat.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
